Cargando…

Addiction in Patients With Cancer: Challenges and Opportunities

Addiction is complex and multifactorial. Recognition provides the opportunity to provide potentially life-saving treatment. Oncology patients are not excluded from substance use disorders (SUDs) and the opioid epidemic. Patients with current or past SUDs may develop cancer, and an SUD may also devel...

Descripción completa

Detalles Bibliográficos
Autores principales: McNally, Gretchen A., Sica, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504925/
https://www.ncbi.nlm.nih.gov/pubmed/34671503
http://dx.doi.org/10.6004/jadpro.2021.12.7.7
_version_ 1784581423344123904
author McNally, Gretchen A.
Sica, Ashley
author_facet McNally, Gretchen A.
Sica, Ashley
author_sort McNally, Gretchen A.
collection PubMed
description Addiction is complex and multifactorial. Recognition provides the opportunity to provide potentially life-saving treatment. Oncology patients are not excluded from substance use disorders (SUDs) and the opioid epidemic. Patients with current or past SUDs may develop cancer, and an SUD may also develop during cancer treatment. Therefore, this unique subset of patients potentially has two fatal diseases: cancer and an SUD. Most oncology advanced practitioners (APs) are unprepared to care for SUDs in patients with cancer. Pain is one of the most common symptoms in the cancer population, and cancer-related pain is often treated with opioids. Opioid exposure increases the risk of developing an opioid use disorder (OUD). In addition, a cancer diagnosis can have a significant impact on mental health and wellness, and patients may use substances to cope with psychological distress. Drug and alcohol use exists on a continuum and while not all use is problematic, it may have adverse consequences. A cancer diagnosis provides another possibility for patients to engage in services and treatment for their unsafe use and/or addiction. The case study in this article of a patient with cancer and an SUD is an example of the challenges associated with the chronic and relapsing nature of addiction. Oncology advanced practitioners have the opportunity to positively influence outcomes through the assessment of substance use and adoption of harm reduction techniques in all patients with cancer.
format Online
Article
Text
id pubmed-8504925
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-85049252021-10-19 Addiction in Patients With Cancer: Challenges and Opportunities McNally, Gretchen A. Sica, Ashley J Adv Pract Oncol Grand Rounds Addiction is complex and multifactorial. Recognition provides the opportunity to provide potentially life-saving treatment. Oncology patients are not excluded from substance use disorders (SUDs) and the opioid epidemic. Patients with current or past SUDs may develop cancer, and an SUD may also develop during cancer treatment. Therefore, this unique subset of patients potentially has two fatal diseases: cancer and an SUD. Most oncology advanced practitioners (APs) are unprepared to care for SUDs in patients with cancer. Pain is one of the most common symptoms in the cancer population, and cancer-related pain is often treated with opioids. Opioid exposure increases the risk of developing an opioid use disorder (OUD). In addition, a cancer diagnosis can have a significant impact on mental health and wellness, and patients may use substances to cope with psychological distress. Drug and alcohol use exists on a continuum and while not all use is problematic, it may have adverse consequences. A cancer diagnosis provides another possibility for patients to engage in services and treatment for their unsafe use and/or addiction. The case study in this article of a patient with cancer and an SUD is an example of the challenges associated with the chronic and relapsing nature of addiction. Oncology advanced practitioners have the opportunity to positively influence outcomes through the assessment of substance use and adoption of harm reduction techniques in all patients with cancer. Harborside Press LLC 2021-09 2021-09-01 /pmc/articles/PMC8504925/ /pubmed/34671503 http://dx.doi.org/10.6004/jadpro.2021.12.7.7 Text en © 2021 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Grand Rounds
McNally, Gretchen A.
Sica, Ashley
Addiction in Patients With Cancer: Challenges and Opportunities
title Addiction in Patients With Cancer: Challenges and Opportunities
title_full Addiction in Patients With Cancer: Challenges and Opportunities
title_fullStr Addiction in Patients With Cancer: Challenges and Opportunities
title_full_unstemmed Addiction in Patients With Cancer: Challenges and Opportunities
title_short Addiction in Patients With Cancer: Challenges and Opportunities
title_sort addiction in patients with cancer: challenges and opportunities
topic Grand Rounds
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504925/
https://www.ncbi.nlm.nih.gov/pubmed/34671503
http://dx.doi.org/10.6004/jadpro.2021.12.7.7
work_keys_str_mv AT mcnallygretchena addictioninpatientswithcancerchallengesandopportunities
AT sicaashley addictioninpatientswithcancerchallengesandopportunities